Microviable participates in a research that has demonstrated that certain microbiota bacteria can be used as new probiotics to improve physical performance.

2024-05-22T12:47:10+02:0022 de May de 2024|

The work, led by a joint IPLA-University of Oviedo research group and the company Microviable Therapeutics, with Susana Delgado, from IPLA-CSIC, as the responsible researcher, has managed to identify and select bacteria in the microbiota [...]